📰 Iagnostics News
Page 17 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
August 14, 2023
Bladder cancer has a five-year survival rate of over 80% when detected early, but this rate declines significantly as the disease progresses to advanced stages.
August 13, 2023
Co-Diagnostics, Inc. (NASDAQ:CODX) Q2 2023 Earnings Call Transcript August 10, 2023 Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $0.24. Operator: Welcome to the Co-Diagnostics Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask […]
August 10, 2023
Fortis and Max Institute reported subdued sequential revenue growth in the June 2023 quarter
August 10, 2023
Doctors have been palpating suspicious hardened areas under their patients' skin throughout recorded history.
August 9, 2023
Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.
August 8, 2023
In this interview, Master Bond describes the features and benefits of medical grade adhesives for medical device manufacturing.
August 8, 2023
Researchers identify potential markers for severe COVID-19 and death in COPD patients.
August 7, 2023
Walmart is making strides in healthcare with 70 HIV-focused specialty pharmacies in 11 states, 6 health centers in Florida and more.
August 4, 2023
Novel blood testing technology being developed by researchers at the Johns Hopkins Kimmel Cancer Center that combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning may allow earlier detection of lung and other cancers.
August 3, 2023
Individuals who have been cured of hepatitis C infection still face a substantially greater risk of death compared with the general population - between 3 and 14 times higher depending on liver disease stage, finds the largest study of its kind published by The BMJ today.